Recombinant Leucine Rich Alpha-2-Glycoprotein 1 (LRG1)RPB934Hu01
Homo sapiens (Human).
<1.0EU per 1µg (determined by the LAL method)
Predicted Molecular Mass
Accurate Molecular Mass
37kDa(Analysis of differences refer to the manual)
Residues & Tags
Thr37~Leu340 with N-terminal His Tag
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
Positive Control; Immunogen; SDS-PAGE; WB.
If bio-activity of the protein is needed, please check active protein.
10µg50µg 200µg 1mg 5mg
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
|Clin Exp Nephrol||Differentially expressed urinary biomarkers in children with idiopathic nephrotic syndrome PubMed: 26351173|
|Journal of Proteome Research||Targeted proteomics predict a sustained complete-response after transarterial chemoembolization and clinical outcomes in patients with hepatocellular carcinoma: a prospective cohort study pubmed:28112944|
|OncoTargets and Therapy||leucine-rich alpha-2-glycoprotein-1 is up-regulated in colorectal cancer and is a tumor promoter Pubmed:29785123|
|PROTEOMICS – Clinical Applications||Screening and Identification of Pregnancy Zone Protein (PZP) and Leucine‐Rich Alpha‐2‐Glycoprotein (LRG) as Potential Serum Biomarkers for Early‐onset … Pubmed: 30411527|
|Cancer Management and Research||iTRAQ-based quantitative protein expression profiling of biomarkers in childhood B-cell and T-cell acute lymphoblastic leukemia Pubmed: 31440093|
|J Clin Med||A Three-Protein Panel to Support the Diagnosis of Sepsis in Children Pubmed:35329889|